These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7923191)

  • 21. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
    Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
    Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C
    Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
    Wang D; Patil S; Li W; Humphrey LE; Brattain MG; Howell GM
    Oncogene; 2002 Apr; 21(18):2785-96. PubMed ID: 11973637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells.
    Sullivan KA; Kim B; Buzdon M; Feldman EL
    Brain Res; 1997 Jan; 744(2):199-206. PubMed ID: 9027379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.
    Vogt A; Wang AS; Johnson CS; Fabisiak JP; Wipf P; Lazo JS
    J Pharmacol Exp Ther; 2000 Feb; 292(2):530-7. PubMed ID: 10640289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.
    Lee CT; Wu S; Gabrilovich D; Chen H; Nadaf-Rahrov S; Ciernik IF; Carbone DP
    Cancer Res; 1996 Jul; 56(13):3038-41. PubMed ID: 8674059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human monoclonal antibodies to the insulin-like growth factor 1 receptor inhibit receptor activation and tumor growth in preclinical studies.
    Runnels HA; Arbuckle JA; Bailey KS; Nicastro PJ; Sun D; Pegg JA; Meyer DM; Evans M; Bono CP; Lie WR; Moffat MA; Casperson GF; Lennard S; Elvin J; Vaughan T; Smith CE; Morton PA
    Adv Ther; 2010 Jul; 27(7):458-75. PubMed ID: 20574692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.
    Maiso P; Ocio EM; Garayoa M; Montero JC; Hofmann F; García-Echeverría C; Zimmermann J; Pandiella A; San Miguel JF
    Br J Haematol; 2008 May; 141(4):470-82. PubMed ID: 18341634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.
    Zhang Y; Zhang Y
    Cancer Invest; 2008; 26(3):230-6. PubMed ID: 18317963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
    J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma.
    Manara MC; Landuzzi L; Nanni P; Nicoletti G; Zambelli D; Lollini PL; Nanni C; Hofmann F; García-Echeverría C; Picci P; Scotlandi K
    Clin Cancer Res; 2007 Feb; 13(4):1322-30. PubMed ID: 17317844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.
    Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW
    Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells.
    Tsuchiya K; Hosoi H; Misawa-Furihata A; Houghton PJ; Sugimoto T
    Int J Oncol; 2007 Jul; 31(1):41-7. PubMed ID: 17549403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.
    Dilling MB; Dias P; Shapiro DN; Germain GS; Johnson RK; Houghton PJ
    Cancer Res; 1994 Feb; 54(4):903-7. PubMed ID: 7508822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo.
    Vincent TS; Hazen-Martin DJ; Garvin AJ
    Cancer Lett; 1996 May; 103(1):49-56. PubMed ID: 8616808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fully human insulin-like growth factor-I receptor antibody SCH 717454 (Robatumumab) has antitumor activity as a single agent and in combination with cytotoxics in pediatric tumor xenografts.
    Wang Y; Lipari P; Wang X; Hailey J; Liang L; Ramos R; Liu M; Pachter JA; Bishop WR; Wang Y
    Mol Cancer Ther; 2010 Feb; 9(2):410-8. PubMed ID: 20124453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autocrine regulation of growth by insulin-like growth factor (IGF)-II mediated by type I IGF-receptor in Wilms tumor cells.
    Qing RQ; Schmitt S; Ruelicke T; Stallmach T; Schoenle EJ
    Pediatr Res; 1996 Jan; 39(1):160-5. PubMed ID: 8825403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.
    De Giovanni C; Melani C; Nanni P; Landuzzi L; Nicoletti G; Frabetti F; Griffoni C; Colombo MP; Lollini PL
    Br J Cancer; 1995 Nov; 72(5):1224-9. PubMed ID: 7577472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.